报告题目：Biomaterial development for anti-infective medical devices
报告时间：2017年4月12日（星期三）下午16:30
报告地点：18新利体育 南区1号楼3楼骨科研究所317学术报告厅
报告人：Dr. Phong Tran,Vice-Chancellor's Research Fellow, Queensland University of Technology, The Institute of Health and Biomedical Innovation
Abstract
Bacterial infections remain a major concern in healthcare. Conventional antibiotic treatments are being challenged by the increase in antibiotic-resistant bacteria. Advances in synthetic chemistry and nanotechnology have resulted in a new class of nanometer-scale materials with distinguished properties and great potential to be an alternative for antibiotics. In this talk, he will introduce some background information of medical-device-associated infections and the emerging opportunities for antibacterial nanomaterials in preventing these complications. He will then discuss my work in the space of nanoparticles and antimicrobial nanoparticles over the last 5 years and some future perspectives of the field.
Biography
Dr. Tran’s research has evolved naturally from nano and biomaterial development and nanomedicine to scaffold design, tissue regeneration and has created strong impacts in the fields. It has resulted in 30 refereed journal articles, two book chapters, two patent applications, 14 conference papers; generated more than 800 citations and attracted more than $1.4 million in funding. As a young researcher, Dr. Tran has succesfully led two externally-funded, interdisciplinary projects that focus on developing and translating local drug delivery technologies into medical applications in 2013-2014. In 2015, Dr. Tran was awarded a prestigious Vice-Chancellor's Research Fellowship at QUT to work with Prof. Dietmar Hutmacher. Here he has intergrated his expertise to recently developed and validated new scaffolding technology that allows for independent control of the bioactivity and the manufacturing of biodegradable polymeric scaffolds by 3D printing. At the end of 2015, he has secured external funding of $10,000 to apply this technology in dental tissue regeneration. In 2017, Dr Tran has been awarded $600,000 research funding for developing a novel antimicrobial surface treatment and drug eluting technology for orthopaedic implants.
